Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1998 1
2000 1
2001 3
2002 2
2004 2
2005 2
2006 4
2007 4
2008 2
2009 14
2010 4
2011 3
2012 7
2013 10
2014 9
2015 9
2016 9
2017 2
2018 4
2019 2
2020 6
2021 6
2022 8
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein.
D'Acunto E, Muzi A, Marchese S, Donnici L, Chiarini V, Bucci F, Pavoni E, Ferrara FF, Cappelletti M, Arriga R, Serrao SM, Peluzzi V, Principato E, Compagnone M, Pinto E, Luberto L, Stoppoloni D, Lahm A, Groß R, Seidel A, Wettstein L, Münch J, Goodhead A, Parisot J, De Francesco R, Ciliberto G, Marra E, Aurisicchio L, Roscilli G. D'Acunto E, et al. Among authors: aurisicchio l. Antibodies (Basel). 2024 Jan 5;13(1):5. doi: 10.3390/antib13010005. Antibodies (Basel). 2024. PMID: 38247569 Free PMC article.
Relevance of Spike/Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2.
Barbieri SS, Cattani F, Sandrini L, Grillo MM, Amendola A, Valente C, Talarico C, Iaconis D, Turacchio G, Lucariello M, Lione L, Salvatori E, Amadio P, Garoffolo G, Maffei M, Galli F, Beccari AR, Sberna G, Marra E, Zoppi M, Michaelides M, Roscilli G, Aurisicchio L, Bertini R, Allegretti M, Pesce M. Barbieri SS, et al. Among authors: aurisicchio l. Signal Transduct Target Ther. 2023 May 19;8(1):203. doi: 10.1038/s41392-023-01488-3. Signal Transduct Target Ther. 2023. PMID: 37208343 Free PMC article. No abstract available.
A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets.
Martins M, do Nascimento GM, Conforti A, Noll JCG, Impellizeri JA, Sanchez E, Wagner B, Lione L, Salvatori E, Pinto E, Compagnone M, Viscount B, Hayward J, Shorrock C, Aurisicchio L, Diel DG. Martins M, et al. Among authors: aurisicchio l. Arch Virol. 2023 Mar 29;168(4):124. doi: 10.1007/s00705-023-05746-1. Arch Virol. 2023. PMID: 36988739 Free PMC article.
A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats.
Conforti A, Sanchez E, Salvatori E, Lione L, Compagnone M, Pinto E, Palombo F, D'Acunto E, Muzi A, Roscilli G, Sun Y, Viscount B, Hayward J, Shorrock C, Diel DG, Impellizeri JA, Aurisicchio L. Conforti A, et al. Among authors: aurisicchio l. Mol Ther Methods Clin Dev. 2023 Mar 9;28:238-248. doi: 10.1016/j.omtm.2022.12.015. Epub 2023 Jan 2. Mol Ther Methods Clin Dev. 2023. PMID: 36618106 Free PMC article.
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19.
Aurisicchio L, Brambilla N, Cazzaniga ME, Bonfanti P, Milleri S, Ascierto PA, Capici S, Vitalini C, Girolami F, Giacovelli G, Caselli G, Visintin M, Fanti F, Ghirri M, Conforti A, Compagnone M, Lione L, Salvatori E, Pinto E, Muzi A, Marra E, Palombo F, Roscilli G, Manenti A, Montomoli E, Cadossi M, Rovati LC. Aurisicchio L, et al. Mol Ther. 2023 Mar 1;31(3):788-800. doi: 10.1016/j.ymthe.2022.12.017. Epub 2022 Dec 27. Mol Ther. 2023. PMID: 36575794 Free PMC article. Clinical Trial.
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.
Fattore L, Cafaro G, Di Martile M, Campani V, Sacconi A, Liguoro D, Marra E, Bruschini S, Stoppoloni D, Cirombella R, De Nicola F, Pallocca M, Ruggiero CF, Castaldo V, Catizone A, Del Bufalo D, Viglietto G, Vecchione A, Blandino G, Aurisicchio L, Fanciulli M, Ascierto PA, De Rosa G, Mancini R, Ciliberto G. Fattore L, et al. Among authors: aurisicchio l. Oncogene. 2023 Jan;42(4):293-307. doi: 10.1038/s41388-022-02547-9. Epub 2022 Nov 23. Oncogene. 2023. PMID: 36418472 Free PMC article.
Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay.
D'Apice L, Trovato M, Gramigna G, Colavita F, Francalancia M, Matusali G, Meschi S, Lapa D, Bettini A, Mizzoni K, Aurisicchio L, Di Caro A, Castilletti C, De Berardinis P. D'Apice L, et al. Among authors: aurisicchio l. Front Immunol. 2022 Sep 26;13:981693. doi: 10.3389/fimmu.2022.981693. eCollection 2022. Front Immunol. 2022. PMID: 36225911 Free PMC article.
DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model.
Compagnone M, Pinto E, Salvatori E, Lione L, Conforti A, Marchese S, Ravà M, Ryan K, Hall Y, Rayner E, Salguero FJ, Paterson J, Iannacone M, De Francesco R, Aurisicchio L, Palombo F. Compagnone M, et al. Among authors: aurisicchio l. Vaccines (Basel). 2022 Jul 25;10(8):1178. doi: 10.3390/vaccines10081178. Vaccines (Basel). 2022. PMID: 35893826 Free PMC article.
110 results